Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha. (2014). Bangladesh Journal of Pharmacology, 9(2), 208-217. https://doi.org/10.3329/bjp.v9i2.18180